Skip to main content
Zhuhai Rundu Pharmaceutical Co., Ltd. logo

Zhuhai Rundu Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002923 ISIN · CNE1000033G8 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,141 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002923

About Zhuhai Rundu Pharmaceutical Co., Ltd.

https://www.rdpharma.cn

Zhuhai Rundu Pharmaceutical Co., Ltd. is an integrated enterprise focused on the research, development, production, and commercialization of chemical drug substances, pharmaceutical intermediates, and finished formulations. The company specializes in therapeutic areas including cardiovascular health, digestive system treatments, and anti-infective medications. Its technical expertise lies in the development of sustained-release and controlled-release delivery systems. Key products include Irbesartan and Hydrochlorothiazide tablets, Rabeprazole Sodium enteric-coated tablets, and various active pharmaceutical ingredients (APIs). By maintaining a complete industrial chain from intermediates to final dosages, the company ensures quality control and supply chain efficiency across its diverse product portfolio.

Recent filings

Filing Released Lang Actions
关于公司控股股东及共同实际控制人部分股份质押的公告
Regulatory Filings Classification · 92% confidence The document is a formal announcement by Zhuhai Rundu Pharmaceutical Co., Ltd. regarding the pledge of shares held by its controlling shareholder and actual controller. It provides details on the number of shares pledged, pledge terms, and related explanations. This is not an AGM material, financial report, earnings or interim report, management discussion, proxy statement, M&A filing, or dividend notice. It also is not a share repurchase by the company or a change in shareholding threshold. Therefore, it falls into the miscellaneous regulatory announcement category.
2026-05-21 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an announcement of the resolutions passed at the company’s 2025 annual general shareholders meeting, including detailed vote counts for each proposal. This matches the definition for “Declaration of Voting Results & Voting Rights Announcements” (DVA), as it reports official shareholder voting results at an AGM.
2026-05-20 Chinese
关于举行2025年度业绩说明会的公告
Investor Presentation Classification · 70% confidence The document is an announcement by Zhuhai Rundu Pharmaceutical Co., Ltd. concerning the schedule and format of its 2025 annual performance explanation meeting for investors, to be held via webcast. This is not the full annual report or earnings release itself, nor a regulatory certification; instead it is an investor‐relations event notice for an upcoming presentation of results. Therefore it best fits the “Investor Presentation” category (IP).
2026-05-11 Chinese
2025年年度审计报告
Regulatory Filings
2026-04-27 Chinese
2026年度董事、高级管理人员薪酬方案
Remuneration Information Classification · 95% confidence The document is a detailed remuneration scheme for board directors and senior management for the 2026 fiscal year, outlining pay principles, compensation structure, approval processes, and performance-based pay. It does not report financial results, announce votes, or request investor action, but specifically details executive and director compensation. This fits the ‘Remuneration Information’ category.
2026-04-27 Chinese
关于2025年度拟不进行利润分配的公告
Notice of Dividend Amount Classification · 92% confidence The document is a formal company announcement regarding the proposed profit distribution for fiscal 2025 (specifically stating there will be no cash dividend, share dividend, or capital reserve conversion). It contains detailed dividend tables, references to regulatory dividend rules, and a board resolution on the dividend plan. This aligns precisely with a Notice of Dividend Amount (DIV) category rather than a general regulatory filing or management change.
2026-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.